GLATIRAMER for Demyelination: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where GLATIRAMER was used for Demyelination.
Most Reported Side Effects for GLATIRAMER
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 5,003 | 10.8% | 2 | 181 |
| Multiple sclerosis relapse | 3,695 | 8.0% | 6 | 718 |
| Drug ineffective | 3,321 | 7.2% | 4 | 168 |
| Injection site reaction | 3,317 | 7.2% | 6 | 95 |
| Multiple sclerosis | 2,596 | 5.6% | 22 | 240 |
| Injection site erythema | 2,560 | 5.5% | 2 | 120 |
| Fatigue | 2,408 | 5.2% | 2 | 273 |
| Dyspnoea | 2,364 | 5.1% | 6 | 366 |
| Injection site mass | 2,172 | 4.7% | 0 | 92 |
| Injection site swelling | 1,836 | 4.0% | 1 | 91 |
| Fall | 1,701 | 3.7% | 7 | 501 |
| Injection site pruritus | 1,579 | 3.4% | 0 | 64 |
| Pain | 1,529 | 3.3% | 1 | 196 |
| Urticaria | 1,366 | 3.0% | 1 | 94 |
| Dizziness | 1,349 | 2.9% | 1 | 215 |
Other Indications for GLATIRAMER
Multiple sclerosis (27,144)
Product used for unknown indication (6,140)
Relapsing-remitting multiple sclerosis (1,965)
Relapsing multiple sclerosis (375)
Multiple sclerosis relapse (133)
Secondary progressive multiple sclerosis (63)
Clinically isolated syndrome (59)
Primary progressive multiple sclerosis (30)
Progressive multiple sclerosis (21)
Rheumatoid arthritis (11)
Other Drugs Used for Demyelination
RITUXIMAB (185)
METHYLPREDNISOLONE (52)
HUMAN IMMUNOGLOBULIN G (41)
TOCILIZUMAB (20)
TERIFLUNOMIDE (19)
OCRELIZUMAB (18)
PREDNISONE (16)
PREDNISOLONE (15)
SATRALIZUMAB-MWGE (15)
DEXAMETHASONE (13)